Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
Clinical trial NCT03147963 · UNKNOWN
Trial details
- NCT number
- NCT03147963
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-20
- Primary completion
- 2019-12-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.